The clinical course of a patient who ingested inorganic mercurial compounds is described. The toxicity of these compounds is discussed and approaches to management outlined. As the long term prognosis in such cases is uncertain, intensive resuscitation and supportive therapy would appear to be justified.
SchreinerG.E., MaherJ.F.Toxic nephropathy. Am J Med1965; 38: 409–449.
6.
KarkR.A.P.Clinical and neurochemical aspects of inorganic mercury intoxication. In: VinkenP.J., BruynG.W., eds. Handbook of clinical neurology. Vol. 36. Intoxications of the nervous system. Part 1. North-Holland, Amsterdam1979; 147–197.
7.
MagosL.Mercury and mercurials. Br Med Bull1975; 31: 241–245.
8.
GosselinR.E., HodgeH.C., SmithR.P., GleasonM.N.Mercury. In: Clinical toxicology of commercial products. Acute poisoning. 4th ed. Williams and Wilkins, Baltimore1976; 223–229.
9.
LongcopeW.T., LuetscherJ.A.Jr., CalkinsE., GrobD., BushS.W., EisenbergH.Clinical uses of 2,3-dimercaptopropanol (BAL). XI. The treatment of acute mercury poisoning by BAL. J Clin Invest1946; 25: 557–567.
10.
GlömmeJ., GustavsonK.H.Treatment of experimental acute mercury poisoning by chelating agents BAL and EDTA. Acta Med Scand1959; 164: 175–182.
11.
MaherJ.F.Toxic and irradiation nephropathies. In: EarleyL.E., GottschalkC.W., eds. Strauss and Welt's Diseases of the kidney. 3rd ed. Little, Brown, Boston1979; 1431–1472.
12.
Sanchez-SiciliaL., SetoD.S., NakamotoS., KolffW.J.Acute mercurial intoxication treated by haemodialysis. Ann Intern Med1963; 59: 692–706.
13.
KarkR.A.P., PoskanzerD.C., BullockJ.D., BoylenG.Mercury poisoning and its treatment with N-acetyl-D, L-penicillamine. N Engl J Med1971; 285: 10–16.
